In an increasingly connected and digital world, the company is meeting people wherever they are and changing health care to meet their needs. The health care benefits segment operates as one of the nation's leading diversified health care benefits providers and has the information and resources to help members make more informed decisions about their health care. The health care benefits segment offers a broad range of health information technology products and services, which are essential for enhancing operational efficiency and supporting business needs. The company believes its innovative health care model increases access to quality care, delivers better health outcomes, and lowers overall health care costs. The corporate/other segment includes management and administrative expenses to support the company's overall operations, which encompass information technology and finance departments, as well as expenses associated with the company's investments in its transformation and enterprise modernization programs. The company expects to benefit from the continuation of its enterprise-wide cost savings initiatives, which aim to reduce the company's operating cost structure in a way that improves the consumer experience and is sustainable. Key drivers include investments in digital, technology, and analytics capabilities that will streamline processes and improve outcomes. The company has also experienced increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure and incremental operating expenses associated with the company's minimum wage investment. The company’s investments in technology and digital capabilities are expected to enhance its operational flexibility and market agility. The pharmacy services segment's adjusted operating income increased primarily driven by improved purchasing economics, which reflects increased contributions from the products and services of the company's group purchasing organization and specialty pharmacy. The company’s ability to drive further improvements in purchasing economics and continued growth in specialty pharmacy is expected to enhance its competitive advantage. The company has recorded a store impairment charge related to the planned closure of approximately 900 retail stores, indicating a strategic realignment of its operational capabilities. The company’s digital transformation efforts are aimed at enhancing its technology infrastructure and operational efficiency, enabling better resource allocation and management capabilities. The company’s strategic resource allocation and investments in IT capabilities are designed to support its business transformation and enhance its competitive positioning in the market. The company's ongoing investments in technology and digital capabilities are expected to facilitate better data management and improve information processing capacity, which are critical for meeting evolving consumer demands and enhancing organizational effectiveness. The company anticipates that the impact of the COVID-19 pandemic will continue to drive changes in consumer behavior and health care utilization patterns, necessitating ongoing adaptations in its operational strategies and technology deployment. The company’s focus on improving its IT systems and capabilities is integral to its overall business strategy and operational performance, ensuring that it remains responsive to market dynamics and competitive forces.